Spots Global Cancer Trial Database for intestinal disease

Every month we try and update this database with for intestinal disease cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Prevention of Progression of Duodenal Adenomas in Patients With Familial Adenomatous Polyposis	NCT00808743	Familial Adenom... Duodenal Neopla... Duodenal Polyps	Celecoxib Ursodeoxycholic... Placebo	18 Years - 70 Years	Radboud University Medical Center
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements	NCT03093116	Locally Advance... Metastatic Soli...	Oral repotrecti...	12 Years -	Turning Point Therapeutics, Inc.
Endorings™ Assisted Colonoscopy Versus Standard Colonoscopy for Polyp Detection	NCT02785783	Colorectal Neop... Intestinal Neop... Digestive Neopl... Digestive Syste... Intestinal Dise... Gastrointestina... Gastrointestina...	Standard colono... EndoRings™	55 Years -	Portsmouth Hospitals NHS Trust
SGM-101 in Colorectal Brain Metastases.	NCT04755920	Rectal Neoplasm... Rectum Cancer Colorectal Neop... Brain Metastase... Brain Neoplasms Brain Diseases Brain Cancer Brain Tumor Intestinal Neop... Gastrointestina... Gastrointestina... Gastrointestina... Intestinal Dise...	SGM-101	18 Years -	Leiden University Medical Center
Prevention of Progression of Duodenal Adenomas in Patients With Familial Adenomatous Polyposis	NCT00808743	Familial Adenom... Duodenal Neopla... Duodenal Polyps	Celecoxib Ursodeoxycholic... Placebo	18 Years - 70 Years	Radboud University Medical Center
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements	NCT03093116	Locally Advance... Metastatic Soli...	Oral repotrecti...	12 Years -	Turning Point Therapeutics, Inc.
Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors	NCT03037385	RET-altered Non... Medullary Thyro... RET-altered Pap... RET-altered Col... RET-altered Sol... Lung Neoplasm Carcinoma, Non-... Thyroid Disease... Thyroid Neoplas... Thyroid Cancer,... Carcinoma, Neur... Respiratory Tra... Thoracic Neopla... Neoplasms by Si... Neoplasms Lung Diseases Respiratory Tra... Carcinoma, Bron... Bronchial Neopl... Endocrine Syste... Endocrine Gland... Head and Neck N... Adenocarcinoma,... Adenocarcinoma Carcinoma Neoplasms, Glan... Neoplasms by Hi... Neuroendocrine ... Neuroectodermal... Neoplasms, Germ... Neoplasms, Nerv... Colonic Neoplas... Colorectal Neop... Intestinal Neop... Gastrointestina... Digestive Syste... Digestive Syste... Gastrointestina... Colonic Disease... Intestinal Dise...	pralsetinib (BL...	18 Years -	Hoffmann-La Roche
Evaluation of Ocoxin®-Viusid® in Metastatic Colorectal Adenocarcinoma	NCT03559543	Colorectal Neop... Intestinal Neop... Gastrointestina... Digestive Syste... Rectal Diseases Colonic Disease... Intestinal Dise... Gastrointestina... Digestive Syste...	Ocoxin-Viusid	18 Years -	Catalysis SL
CRC Detection Reliable Assessment With Blood	NCT05551052	Colorectal Canc... Adenomas Colon Colon Cancer Rectal Cancer Colon Neoplasm Colon Lesion Colon Disease Colon Polyp Polyps Adenoma Rectal Diseases Rectal Polyp Gastrointestina... Intestinal Neop... Colonic Disease... Intestinal Dise...	Next-Gen CRC Sc...	45 Years -	Epigenomics, Inc
Evaluation of Ocoxin®-Viusid® in Metastatic Colorectal Adenocarcinoma	NCT03559543	Colorectal Neop... Intestinal Neop... Gastrointestina... Digestive Syste... Rectal Diseases Colonic Disease... Intestinal Dise... Gastrointestina... Digestive Syste...	Ocoxin-Viusid	18 Years -	Catalysis SL
Gut Microbiota and Color-rectal Cancer.	NCT04662853	Cancer Colo-rectal Can... Diagnoses Disea... Microbiota-rela... Intestinal Dise...	Gut microbiota ...	50 Years - 69 Years	Maimónides Biomedical Research Institute of Córdoba
Intraoperative TAP Block With Bupivacaine/Dexamethasone Against Liposomal Bupivacaine (Exparel®)	NCT03723447	Pain, Postopera... Crohn Disease Inflammatory Bo... Colorectal Canc... Gastrointestina... Gastrointestina... Digestive Syste... Pain Pain, Neuropath... Intestinal Dise...	Liposomal bupiv... Bupivacaine/epi...	18 Years - 90 Years	Cedars-Sinai Medical Center

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: